In accordance with TGCA data, we found reduced expression of DNAM1 both in tumor infiltrating NK cells isolated from lung tumor biopsies (primary and metastatic lesions) and in peripheral blood NK cells from patients with lung cancer (Figure 4E,F and Figure S3C). This evidence concerns the gene CD226 and neoplasm.